XML 54 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions and Joint Venture - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 17, 2021
Mar. 31, 2022
Oct. 31, 2022
Jul. 31, 2022
Jul. 31, 2022
Jul. 31, 2021
Oct. 31, 2021
Feb. 01, 2021
Jan. 19, 2021
Business Acquisition [Line Items]                  
Finite-lived intangible asset, useful life         13 years        
Goodwill       $ 3,665,800,000 $ 3,665,800,000   $ 2,574,000,000    
Proceeds from sale of interest in a subsidiary   $ 52,100,000     $ 52,100,000 $ 0      
Payments to form joint venture   10,000,000              
Equity method investments   90,000,000              
Equity method investment realized gain   $ 56,900,000              
SightGlass Vision, Inc.                  
Business Acquisition [Line Items]                  
Equity method investment, ownership percentage   50.00%   50.00% 50.00%        
Essilor International SAS                  
Business Acquisition [Line Items]                  
Payments to form joint venture   $ 10,000,000              
Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System                  
Business Acquisition [Line Items]                  
Goodwill               $ 0  
Composite intangible asset                  
Business Acquisition [Line Items]                  
Finite-lived intangible asset, useful life         15 years        
Trademarks                  
Business Acquisition [Line Items]                  
Finite-lived intangible asset, useful life         14 years        
Line of Credit | Term Loan Facility 2021                  
Business Acquisition [Line Items]                  
Proceeds from line of credit $ 1,500,000,000                
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event                  
Business Acquisition [Line Items]                  
Aggregate consideration     $ 875,000,000            
Payments to acquire business     675,000,000            
Payables incurred in acquisition     200,000,000            
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables First Installment                  
Business Acquisition [Line Items]                  
Payables incurred in acquisition     50,000,000            
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Second Installment                  
Business Acquisition [Line Items]                  
Payables incurred in acquisition     50,000,000            
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Third Installment                  
Business Acquisition [Line Items]                  
Payables incurred in acquisition     50,000,000            
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Fourth Installment                  
Business Acquisition [Line Items]                  
Payables incurred in acquisition     $ 50,000,000            
Generate Life Sciences                  
Business Acquisition [Line Items]                  
Payments to acquire business $ 1,663,000,000                
Ownership percentage 100.00%                
Measurement period adjustment to goodwill       $ 33,800,000 $ 96,100,000        
Actual revenue generated         177,300,000        
Actual net income generated         $ 20,900,000        
Goodwill $ 1,196,500,000                
Generate Life Sciences | Composite intangible asset                  
Business Acquisition [Line Items]                  
Finite-lived intangible asset, useful life         13 years        
Generate Life Sciences | Trademarks                  
Business Acquisition [Line Items]                  
Finite-lived intangible asset, useful life         14 years        
Generate Life Sciences | Line of Credit | Term Loan Facility 2021                  
Business Acquisition [Line Items]                  
Proceeds from line of credit $ 1,500,000,000                
Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners                  
Business Acquisition [Line Items]                  
Undiscounted range of the contingent consideration, minimum                 $ 0
Undiscounted range of the contingent consideration, maximum                 $ 139,100,000
Payment to settle former equity interest owners   $ 42,900,000              
Net gains recognized       0 $ 12,200,000        
Contingent consideration       $ 31,800,000 $ 31,800,000